Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

Egg based and non egg based flu vaccines were equally effective at preventing influenza like illness among healthy adults ...

Combined Intraperitoneal and Intravenous Chemotherapy for Women With Optimally Debulked Ovarian Cancer: Results From an Intergroup Phase II Trial Purpose: To evaluate in vivo whether the expression of ...

Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its Codex® HiTemp Reverse Transcriptase for use in one-step ...

Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.

Management and Outcome Differences in Supraglottic Cancer Between Ontario, Canada, and the Surveillance, Epidemiology, and End Results Areas of the United States Purpose: To determine whether reverse ...

Expert Rev Mol Diagn. 2009;9(8):777-785. Traditional paradigms for staging patients with colorectal cancer incorporating standard histopathological assessment of regional lymph nodes underestimate the ...

New England Biolabs (NEB®) announced today that they have released a novel, thermostable reverse transcriptase, WarmStart® RTx Reverse Transcriptase, specifically designed for nucleic acid detection.

In this ‘Peek behind the paper’, Elena Martens-Uzunova (left), Assistant Professor in the Department of Urology at the Erasmus University Medical Center (Rotterdam, The Netherlands), discusses her ...

Researchers have built an RT-PCR platform that gives results in 23 minutes that match the longer laboratory-based tests -- faster than other PCR tests on the market. It can be adapted to test for a ...